Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$12.5 - $24.78 $3,337 - $6,616
267 Added 2.24%
12,170 $174,000
Q3 2022

Nov 04, 2022

SELL
$20.6 - $30.37 $11,783 - $17,371
-572 Reduced 4.59%
11,903 $304,000
Q2 2022

Aug 01, 2022

SELL
$26.05 - $37.48 $29,202 - $42,015
-1,121 Reduced 8.25%
12,475 $354,000
Q1 2022

May 10, 2022

SELL
$24.46 - $40.92 $34,317 - $57,410
-1,403 Reduced 9.35%
13,596 $480,000
Q4 2021

Feb 08, 2022

SELL
$35.0 - $45.94 $93,660 - $122,935
-2,676 Reduced 15.14%
14,999 $628,000
Q3 2021

Nov 12, 2021

BUY
$36.8 - $60.62 $39,964 - $65,833
1,086 Added 6.55%
17,675 $867,000
Q2 2021

Aug 12, 2021

BUY
$32.46 - $45.0 $538,478 - $746,505
16,589 New
16,589 $692,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $919M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.